Furthermore, mice with a haploinsufficiency in NUAK1 revealed a decrease in Tau in the brain; whereas human tissues from AD patients revealed that Tau protein overexpression correlates with NUAK1 upregulation. Here, MAPT is linked to Alzheimer disease.